|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Spectranetics Corporation, a specialized producer of excimer laser systems to photo-ablate lesions and vaporize blockages in the legs. |
|---|---|
| Transferring Party | Kensey Nash Corporation (NASDAQ: KNSY), A maker of vascular puncture closure, biomaterials and endovascular products for tissue fixation and regeneration. |
| Sector | Medical Devices |
| Date | June 2, 2008 |
| Analysis Strengthens Stratranetics' presence in the treatment of thrombus and chronic total occlusions and complements Spectrnetics' laser ablation systems. Deal value -- $10m, plus $14m in earnouts for sales, product development and FDA approval milestones. The product lines generated $5.1m in sales in 07. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |